Tag: ResMed

SAN DIEGO – ResMed was able to take its AirSense 10 fully connected CPAP device off allocation in the U.S. market in January, CEO Mick Farrell said during a conference call to discuss its financial results for the second quarter fiscal year 2023.  Furthermore, the company expects to be able to meet all demand before the end of this calendar year, he said, paving the way for providers to get patients on therapy in days or weeks vs. months at the height of a supply crisis created by a...

AUCKLAND, New Zealand – Fisher & Paykel Healthcare expects full year operating revenue for the 2023 financial year to be within the range of about $1.55 billion to $1.6 billion, the company announced on Jan. 19.  In F&P’s Homecare Product Group, sales of obstructive sleep apnea masks have remained strong, said Lewis Gradon, managing director and CEO.  “Our mask sales growth rate is currently tracking above that of our first half as global supply of CPAP hardware...

SAN DIEGO – ResMed reported revenue increased by 16% to $1.03 billion in the second quarter of fiscal year 2023 compared to the same period the previous year.  Net income was $224.9 million vs. $216.2 million.  “During the second quarter, we significantly increased production and delivery of flow generator devices to meet the incredible demand from customers, resulting in strong sales growth in the Americas, and solid overall performance for our business across 140 countries,”...

YARMOUTH, Maine – Several HME companies have made the Power 500 Technology Companies list, a nod to their commitment to improving the health of people around the world. In the Medical Devices category, ResMed, Dexcom, Insulet Corp., AdaptHealth and Masimo were all listed as leaders. The list includes companies that demonstrate product or service leadership, technical depth in their specific fields, consistent organizational growth or evolution, operational excellence and high-caliber management...

SAN DIEGO and HILDESHEIM, Germany – ResMed has completed its acquisition of MEDIFOX DAN for 958.6 million Euros. MEDIFOX DAN, which is headquartered in Hildesheim, Germany, and employs 700, now operates under its current brand within the ResMed SaaS business segment, which also includes Brightree and MatrixCare. “We’re excited to have closed this important expansion of our SaaS business and to officially welcome MEDIFOX DAN to our ResMed SaaS team and global ResMed family,”...

SAN DIEGO – ResMed has more than doubled its footprint in Singapore with a new 270,000-square-foot manufacturing facility.  The new facility will serve as ResMed’s key manufacturing hub in Asia-Pacific.   “Singapore’s strategic location and support for business investment, coupled with ResMed’s world-leading devices and digital health offerings, provides the perfect opportunity to expand our manufacturing capabilities, while supporting local jobs and...

LAS VEGAS – Primasun, a solution to address complex sleep disorders that was formed as a joint venture between ResMed and Verily, launched at the HLTH 2022 event on Nov. 13.  Through its preventative care model, Primasun works with employers and health care providers to identify populations at risk and connects patients to certified sleep physicians who guide them from diagnosis to treatment in a matter of weeks.  "Sleep is the foundation of physical and mental health, and at...

  SAN DIEGO – ResMed’s card-to-cloud CPAP device, launched earlier in 2022, provided “meaningful growth” for the first quarter of the company’s fiscal year 2023, said CEO Mick Farrell.  The AirSense 10 card-to-cloud device is one of the company’s workarounds for pumping product into the market amid a competitor’s recall that has significantly increased demand and supply chain challenges that have limited the supply of semiconductor chips,...

SAN DIEGO – ResMed reported that revenue increased 5% to $950.3 million and net income increased 3% to $210.5 million in the first quarter of fiscal year 2023 compared to the same period last year.  Revenue in the U.S., Canada, and Latin America, excluding software-as-a-service, grew 18%, primarily due to increased demand and reduced competitive supply, as well as a recovery of core sleep patient flow that was previously impacted by COVID-19.  “Our first quarter fiscal...

  SAN DIEGO – As Lucile Blaise takes on a larger role at ResMed, she is prioritizing, among other things, advocating for new forms of reimbursement for digital health.  Here’s what Blaise, who was promoted from ResMed’s vice president of Sleep & Respiratory Care for Western Europe to president of its global business this summer, had to say about why everyone wins when sleep apnea is diagnosed and treated.  HME News: CEO Mick Farrell often talks about the...